Clinical Trials Directory

Trials / Completed

CompletedNCT00540813

Paclitaxel-Eluting Balloon Angioplasty and Coroflex™-Stents in the Treatment of Bifurcated Coronary Lesions

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
28 (actual)
Sponsor
Heart Centre Rotenburg · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of the study is to investigate the feasibility of Paclitaxel-eluting PTCA-balloon dilation (SeQuent Please) followed by bare metal stent (Coroflex ) deployment in the main branch (reference diameter: ≥ 2.5 mm and ≤ 3.8 mm, reference diameter of side branch: ≥ 2.0 mm and ≤ 3.5 mm, length of stenoses in either branch ≤ 20 mm) in the treatment of significant (\>70%) de-novo-bifurcation stenoses of any Medina classification type in the native left coronary artery as reflected by procedural success and to evaluate the preservation of vessel patency.

Conditions

Interventions

TypeNameDescription
DEVICEdrug eluting balloondrug eluting balloon bifurcated coronary lesions single arm study

Timeline

Start date
2007-10-01
Primary completion
2011-05-01
Completion
2016-10-01
First posted
2007-10-08
Last updated
2017-02-23

Locations

2 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT00540813. Inclusion in this directory is not an endorsement.

Paclitaxel-Eluting Balloon Angioplasty and Coroflex™-Stents in the Treatment of Bifurcated Coronary Lesions (NCT00540813) · Clinical Trials Directory